Cargando…
Fibroblast growth factor signalling influences homologous recombination-mediated DNA damage repair to promote drug resistance in ovarian cancer
BACKGROUND: Ovarian cancer patients frequently develop chemotherapy resistance, limiting treatment options. We have previously shown that individuality in fibroblast growth factor 1 (FGF1) expression influences survival and chemotherapy response. METHODS: We used MTT assays to assess chemosensitivit...
Autores principales: | Nicholson, Hugh A., Sawers, Lynne, Clarke, Rosemary G., Hiom, Kevin J., Ferguson, Michelle J., Smith, Gillian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519926/ https://www.ncbi.nlm.nih.gov/pubmed/35778553 http://dx.doi.org/10.1038/s41416-022-01899-z |
Ejemplares similares
-
DHX9-dependent recruitment of BRCA1 to RNA promotes DNA end resection in homologous recombination
por: Chakraborty, Prasun, et al.
Publicado: (2021) -
ATR Suppresses Endogenous DNA Damage and Allows Completion of Homologous Recombination Repair
por: Brown, Adam D., et al.
Publicado: (2014) -
RAD18 transmits DNA damage signaling to elicit homologous recombination repair
por: Huang, Jun, et al.
Publicado: (2009) -
Polymorphism of DNA Repair Genes via Homologous Recombination (HR) in Ovarian Cancer
por: Smolarz, Beata, et al.
Publicado: (2019) -
Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells
por: Xie, Lisha, et al.
Publicado: (2016)